Back
Jazz Pharmaceuticals PLC Vs. Alkermes PLC Industry Stock Comparison
Sell
48
JAZZ
Jazz Pharmaceuticals PLC
Last Price:
112.78
Seasonality Move:
6.6%
Sell
45
ALKS
Alkermes PLC
Last Price:
29.12
Seasonality Move:
11.73%
Sell
48
Jazz Pharmaceuticals PLC (JAZZ)
is a Sell
Is Jazz Pharmaceuticals PLC a Buy, Sell or Hold?
- The current Jazz Pharmaceuticals PLC [JAZZ] share price is $111.43. The Score for JAZZ is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- JAZZ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Alkermes PLC (ALKS)
is a Sell
Is Alkermes PLC a Buy, Sell or Hold?
- The current Alkermes PLC [ALKS] share price is $28.37. The Score for ALKS is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- ALKS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
JAZZ Stock Price Chart
What is Jazz Pharmaceuticals PLC's stock price today?
-
The Jazz Pharmaceuticals PLC share price today is $111.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JAZZ is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALKS Stock Price Chart
What is Alkermes PLC's stock price today?
-
The Alkermes PLC share price today is $28.37
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALKS is experiencing buying pressure, which is a positive indicator for future bullish movement.
JAZZ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.12 | Buy |
| Relative Strength Index (14 RSI): | 51.15 | Buy |
| Chaikin Money Flow: | 504066 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (108.17 - 113.31) | Buy |
| Bollinger Bands (100): | (106.49 - 113.29) | Buy |
ALKS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.25 | Sell |
| Relative Strength Index (14 RSI): | 57.15 | Buy |
| Chaikin Money Flow: | 2089977 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.55 - 28.59) | Buy |
| Bollinger Bands (100): | (25.07 - 28.25) | Buy |
JAZZ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.92 | Buy |
| 20-day SMA: | 111.17 | Buy |
| 50-day SMA: | 110.48 | Buy |
| 200-day SMA: | 113 | Sell |
| 8-day EMA: | 110.91 | Buy |
| 20-day EMA: | 110.95 | Buy |
| 50-day EMA: | 110.64 | Buy |
| 200-day EMA: | 113.82 | Sell |
ALKS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 26.56 | Buy |
| 20-day SMA: | 27.32 | Buy |
| 50-day SMA: | 27.61 | Buy |
| 200-day SMA: | 26.53 | Buy |
| 8-day EMA: | 26.98 | Buy |
| 20-day EMA: | 27.2 | Buy |
| 50-day EMA: | 27.28 | Buy |
| 200-day EMA: | 26.77 | Buy |
Jazz Pharmaceuticals PLC Earnings Growth & JAZZ Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.28 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.04 per share, and an increase next year of $2.05 per share.
Alkermes PLC Earnings Growth & ALKS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.97 per share, and a decrease next year of $0.78 per share.
Jazz Pharmaceuticals PLC Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alkermes PLC Technical Analysis
| Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||